Cargando…
Real-World Effectiveness, Safety, and Health-Related Quality of Life in Patients Receiving Adjuvant Nivolumab for Melanoma in Belgium and Luxembourg: Results of PRESERV MEL †
SIMPLE SUMMARY: PRESERV MEL (Prospective and REtrospective Study of nivolumab thERapy in adjuVant MELanoma) is a real-world observational study evaluating the effectiveness and safety of adjuvant nivolumab in patients with completely resected stage III or stage IV melanoma in clinical practice in Be...
Autores principales: | Rogiers, Anne, Willemot, Laurence, McDonald, Laura, Van Campenhout, Hilde, Berchem, Guy, Jacobs, Celine, Blockx, Nathalie, Rorive, Andrée, Neyns, Bart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572061/ https://www.ncbi.nlm.nih.gov/pubmed/37835517 http://dx.doi.org/10.3390/cancers15194823 |
Ejemplares similares
-
Enteroaggregative Shiga toxin-producing Escherichia coli of serotype O104:H4 in Belgium and Luxembourg
por: De Rauw, K, et al.
Publicado: (2014) -
Phase II study of autologous mRNA electroporated dendritic cells (TriMixDC-MEL) in combination with Ipilimumab in patients with pretreated advanced melanoma
por: Thielemans, Kris, et al.
Publicado: (2014) -
A population based economic analysis of cross-border payments for fertility services in Luxembourg
por: Jones, Christopher A., et al.
Publicado: (2010) -
New insight in lymnaeid snails (Mollusca, Gastropoda) as intermediate hosts of Fasciola hepatica (Trematoda, Digenea) in Belgium and Luxembourg
por: Caron, Yannick, et al.
Publicado: (2014) -
Science Production in Germany, France, Belgium, and Luxembourg: Comparing the Contributions of Research Universities and Institutes to Science, Technology, Engineering, Mathematics, and Health
por: Powell, Justin J.W., et al.
Publicado: (2017)